top of page

ASGCT 2026: Coave Therapeutics has a unique conjugation approach to delivering AAV to the right place in the body - at ASGCT they presented on the platform and lead internal program for wet AMD

10 hours ago
1 min read

CEO Rodolphe Clerval describes the platform, which they can partner using a company's existing AAV assets or with Coave's new OneAAV universal capsid. Plus, why he thinks Coave's wet AMD program, which will be administered at the point of care, could be best in class.

https://vimeo.com/1192098934

Coverage brought to you by

Recent Posts

ASGCT 2026: Rgenta Therapeutics has been developing oral small molecules to regulate RNA - after starting with endogenous targets, they realized they could do the same for transgene expression

ASGCT 2026: Rgenta Therapeutics has been developing oral small molecules to regulate RNA - after starting with endogenous targets, they realized they could do the same for transgene expression

ASGCT 2026: Siren Biotechnology recently has seen two INDs cleared for its AAV based gene therapy for oncology. Founder Nicole Paulk discusses how they are prepared to enter the clinic shortly

ASGCT 2026: Siren Biotechnology recently has seen two INDs cleared for its AAV based gene therapy for oncology. Founder Nicole Paulk discusses how they are prepared to enter the clinic shortly

ASGCT 2026: Barcelona based Integra Therapeutics believes its FiCAT gene writing platform can deliver a larger payload capacity and with more precision than with traditional viral vectors

ASGCT 2026: Barcelona based Integra Therapeutics believes its FiCAT gene writing platform can deliver a larger payload capacity and with more precision than with traditional viral vectors

Follow BiotechTV

Also look for unique social pages for BiotechTV U.

Sponsors

NYSE_logo_large_no reg_378x197 (1).png

Learn more about our sponsors

Sponsor Spotlight

HSBC Innovation Banking's dedicated sector experts possess in-depth knowledge of the technology, life science and healthcare economies. With access to an extensive global network, we can help you fuel growth through venture capital and corporate investors, industry influencers, customers, and global opportunities.

Through our interconnected innovation hubs in the US, UK, Israel and Hong Kong, our experts are supporting the world’s innovation economy – both clients and their investors to help them meet their growth goals.

bottom of page